Skip to main content
Smart Investors Daily
IN

NYSE · INSP

Inspire Medical Systems, Inc.

Healthcare · Medical - Devices

$56.28

Down-$1.83 (-3.15%)

Updated Nov 20, 2026, 2:09 AM

SID Score

3.1/10

Composite research score

Smart Money

58/100

Neutral

Market cap
4.05B
P/E ratio
76.09
Dividend yield
0.00%
52-week range
$38.91 – $147.03
Volume
614.74K
Avg. volume
1.3M

Price performance · INSP

INSP price history

1M range · 0 trading sessions · Daily adjusted prices

INSP does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest INSP news

The latest Smart Investors Daily articles mentioning INSP.

INSP research

Overview

Company profile and research snapshot.

Company profile

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$139.92
Implied upside
—
Analysts
—
INSP recent ratings
DateFirmRatingTarget
Nov 13, 2026Freedom Capital MarketsBuy—
Nov 3, 2026BarclaysUnderweight—
Nov 3, 2026Evercore ISI GroupIn-Line—
Nov 3, 2026Wells FargoEqual-Weight—
Nov 3, 2026Truist SecuritiesHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 5, 2026

Has Inspire Medical Systems (INSP) Fallen Far Enough on Cash Flow?

Inspire Medical Systems has seen its share price decline sharply in recent years, which puts fresh focus on whether the current valuation is aligned with the cash it can realistically generate. With sentiment being reshaped by recent operating updates, the question now is how much of the company’s future cash flows are already baked into today’s price. The stock has fallen 75.3% over the past 5 years, which raises the question of whether investors have reassessed the long term cash flow...

Yahoo · Nov 5, 2026

Inspire Medical Systems Stock Has The Bull Case Changed After Narrowed Guidance

Inspire Medical Systems reported Q3 2026 revenue of US$206.7 million and a net loss of US$24.4 million, with full year sales guidance tightened to US$850 million to US$860 million and billing and coding issues still weighing on results. The business paired weaker headline sales and a swing to losses with revenue and adjusted earnings that came in ahead of expectations, while also pointing to longer term reimbursement changes, such as a new Category I CPT code from 2028, that could influence...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.